Novo Nordisk A/S (NONOF)
42.42
-1.25
(-2.87%)
USD |
OTCM |
Sep 15, 16:00
Novo Nordisk Price : 42.42 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 42.21 | 43.26 | 41.94 | 42.42 | 225264.0 |
| Sep 14, 2026 | 41.21 | 44.26 | 41.21 | 43.67 | 5124.00 |
| Sep 11, 2026 | 43.93 | 43.93 | 42.00 | 43.19 | 14651.00 |
| Sep 10, 2026 | 44.56 | 45.39 | 42.98 | 44.14 | 12753.00 |
| Sep 09, 2026 | 45.76 | 45.76 | 43.51 | 44.47 | 3462.00 |
| Sep 08, 2026 | 43.15 | 46.30 | 43.15 | 45.44 | 10568.00 |
| Sep 04, 2026 | 43.88 | 47.00 | 43.88 | 46.31 | 1840.00 |
| Sep 03, 2026 | 45.56 | 47.50 | 45.50 | 46.50 | 7400.00 |
| Sep 02, 2026 | 46.50 | 47.55 | 45.02 | 46.85 | 11552.00 |
| Sep 01, 2026 | 45.01 | 46.59 | 44.85 | 45.35 | 9289.00 |
| Aug 31, 2026 | 42.78 | 45.93 | 42.78 | 45.25 | 32656.00 |
| Aug 28, 2026 | 43.90 | 46.31 | 43.90 | 45.02 | 6482.00 |
| Aug 27, 2026 | 46.25 | 46.70 | 44.00 | 46.16 | 286690.0 |
| Aug 26, 2026 | 48.11 | 48.34 | 46.22 | 47.39 | 253277.0 |
| Aug 25, 2026 | 47.17 | 48.50 | 47.00 | 48.12 | 304197.0 |
| Aug 24, 2026 | 47.90 | 47.90 | 46.60 | 47.00 | 82821.00 |
| Aug 21, 2026 | 46.74 | 47.46 | 46.38 | 46.81 | 655220.0 |
| Aug 20, 2026 | 47.69 | 47.69 | 45.51 | 46.33 | 86988.00 |
| Aug 19, 2026 | 47.30 | 47.30 | 44.97 | 45.40 | 4281.00 |
| Aug 18, 2026 | 43.15 | 45.55 | 43.15 | 44.92 | 47644.00 |
| Aug 17, 2026 | 45.98 | 45.98 | 44.50 | 45.11 | 3632.00 |
| Aug 14, 2026 | 47.00 | 47.19 | 43.67 | 45.14 | 4545.00 |
| Aug 13, 2026 | 45.45 | 47.00 | 44.95 | 45.79 | 3832.00 |
| Aug 12, 2026 | 43.59 | 46.68 | 43.36 | 45.71 | 4461.00 |
| Aug 11, 2026 | 48.37 | 48.37 | 46.91 | 46.91 | 1.503M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1136.11 |
| ALK-Abello A/S | 32.47 |
| H. Lundbeck A/S | 6.755 |
| Dr. Reddy's Laboratories Ltd. | 11.55 |
| Neumora Therapeutics, Inc. | 0.8313 |
Price Related Metrics
| PE Ratio | 10.37 |
| PS Ratio | 3.665 |
| PEG Ratio | 0.8227 |
| Price to Book Value | 5.540 |
| Price to Free Cash Flow | 25.59 |
| Earnings Yield | 9.65% |
| Market Cap | 187.51B |
| PEGY Ratio | 0.6154 |
| Operating PE Ratio | 8.077 |
| Normalized PE Ratio | 9.964 |